Botanical species · safety record

Lyonia ovalifolia

The EFSA Compendium of Botanicals holds 5 constituent measurements for Lyonia ovalifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lyonia ovalifolia var. elliptica (Siebold & Zucc.) Hand.-Mazz.

5Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Diterpenes	Leaves	—	—	Unspecified	Resolve DOI
Lignans	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lignans	Wood	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Lignans	Unspecified	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Lignans	Leaves	Solvent extraction	—	Traditional analytical techniques (wet chemical tests)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Kashima, Kenji., Sano, Kaichi., Yun, Young Sook., Ina, Hiroji., Kunugi, Akira., Inoue, Hideshi. Ovafolinins A-E, Five New Lignans from Lyonia ovalifolia. Chemical & pharmaceutical bulletin, 2010, vol. 58, no. 2, p. 191-194.
HOTTA, Y., TAKEYA, K., KOBAYASHI, S., HARADA, N., SAKAKIBARA, J., SHIRAI, N. RELATIONSHIP BETWEEN STRUCTURE, POSITIVE INOTROPIC POTENCY AND LETHAL DOSE OF GRAYANOTOXINS IN GUINEA-PIG . Archives of toxicology, 1980, vol. 44, no. 4, p. 259-267. DOI
Yasue, Masaiti., Kato, Takeshi., Sakakibara, Jinsaku. Structure of lyoniol-A (lyoniatoxin). Chemical & pharmaceutical bulletin, 1970, vol. 18, no. 4, p. 854-6.
Rahman, Md. Atiar., Katayama, Takeshi., Suzuki, Toshisada., Nakagawa, Takashi. Stereochemistry and biosynthesis of (+)-lyoniresinol, a syringyl tetrahydronaphthalene lignan in Lyonia ovalifolia var. elliptica I: isolation and stereochemistry of syringyl lignans and predicted precursors to (+)-lyoniresinol from wood . Journal of wood science, 2007, vol. 53, no. 2, p. 161-167. DOI
YASUE, M., OTA, H., KISHIDA, T., KATO, Y. ISOLATION OF LYONIOL-A, -B, AND -C, TOXIC PRINCIPLES OF LYONIA OVALIFOLIA VAR ELLIPTICA . Chemical & pharmaceutical bulletin, 1961, vol. 9, no. 2, p. 171-+.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature